Chenodeoxycholic Acid News

Chenodeoxycholic Acid currently has 12 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Chenodeoxycholic Acid with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Original indication: Chenodeoxycholic acid is indicated for the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (CTX)) in...
Evidence level: L5
Predicted indications (20):
- cholelithiasis (99.8%)
- homozygous familial hypercholesterolemia (99.6%)
- brain small vessel disease 1 with or without ocular anomalies (99.4%)
- autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome (99.4%)
- obsolete familial combined hyperlipidemia (99.3%)
- obsolete hyperuricemia (disease) (99.3%)
- hypouricemia, renal (98.9%)
- diabetic nephropathy (98.8%)
- hypoxanthine guanine phosphoribosyltransferase partial deficiency (97.8%)
- familial isolated hypoparathyroidism due to impaired PTH secretion (97.5%)
- Lesch-Nyhan syndrome (97.5%)
- biotin metabolic disease (97.1%)
- renal tubular acidosis (96.9%)
- acromesomelic dysplasia, Campailla Martinelli type (96.7%)
- Dahlberg-Borer-Newcomer syndrome (96.7%)
- vitamin deficiency disorder (96.7%)
- congestive heart failure (96.5%)
- craniofacial conodysplasia (96.4%)
- pseudo-von Willebrand disease (96.3%)
- primary release disorder of platelets (96.2%)